Margaret Cabano
Directeur des opérations chez NEOS THERAPEUTICS, INC.
Profil
Margaret Cabano is currently the Vice President of Operations at Neos Therapeutics, Inc. and Aytu Biopharma, Inc. She previously worked as a Principal at Cardinal Health, Inc. and Adams Respiratory Therapeutics, Inc. Cabano received her undergraduate degree and MBA from the University of North Texas.
Postes actifs de Margaret Cabano
| Sociétés | Poste | Début |
|---|---|---|
| NEOS THERAPEUTICS, INC. | Directeur des opérations | 01/01/2005 |
| AYTU BIOPHARMA, INC. | Directeur des opérations | 01/01/2005 |
Anciens postes connus de Margaret Cabano
| Sociétés | Poste | Fin |
|---|---|---|
| CARDINAL HEALTH, INC. | Corporate Officer/Principal | - |
Adams Respiratory Therapeutics, Inc.
 Adams Respiratory Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adams Respiratory Therapeutics, Inc. manufactures over-the-counter remedies for respiratory ailments. The company's products include Mucinex, Mucinex DM, Maximum Strength Mucinex, Mucinex DM, Mucinex D, and the Delsym. It is a subsidiary of Reckitt Benckiser Corp. Adams Respiratory Therapeutics is headquartered in Chester, NJ | Corporate Officer/Principal | - |
Formation de Margaret Cabano
| University of North Texas | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CARDINAL HEALTH, INC. | Distribution Services |
| AYTU BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Neos Therapeutics, Inc.
 Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX. | Health Technology |
Adams Respiratory Therapeutics, Inc.
Adams Respiratory Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adams Respiratory Therapeutics, Inc. manufactures over-the-counter remedies for respiratory ailments. The company's products include Mucinex, Mucinex DM, Maximum Strength Mucinex, Mucinex DM, Mucinex D, and the Delsym. It is a subsidiary of Reckitt Benckiser Corp. Adams Respiratory Therapeutics is headquartered in Chester, NJ | Health Technology |
